Signal active
Investment Firm
Overview
Safeguard Scientifics, Inc. (NYSE: SFE) has a distinguished track record of fostering innovation and building market leaders. For more than 60 years, Safeguard has been providing growth capital and operational support to entrepreneurs across an evolving spectrum of industries. Today, Safeguard is focused specifically on healthcare and technology. Safeguard is a proven partner for entrepreneurs looking to accelerate growth and build long-term value in their businesses. Investors in NYSE:SFE have a unique opportunity to tap into the high potential of Safeguard's early- and growth-stage partners companies.
Highlights
1953
Financial Services
11-50
129
74
41
Late Stage Venture, Early Stage Venture, Private Equity, Seed
Private Equity Firm
Location
Radnor, Pennsylvania, United States, North America
Contact Information
Social
Profile Resume
Safeguard Scientifics, established in 1953 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture, Private Equity, Seed investments across E-Commerce, Video, Retail, Online Portals, Gaming, Video Games, Shopping, Finance, Biotechnology, Health Care. The organization boasts a portfolio of 129 investments, with an average round size of $16.0M and 41 successful exits. Their recent investments include Swaptree Inc., Alverix, New Venture Partners, Avid Radiopharmaceuticals, OUP (Osage University Partners). The highest investment round they participated in was $114.8B. Among their most notable exits are Swaptree Inc. and Alverix. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
129
13
74
41
Investments
129
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Jan 11, 2021 | Moxe Health | Health Care | null |
Jun 01, 2022 | Moxe Health | Health Care | 30.0M |
Jul 27, 2022 | Syapse | Cloud Computing | 35.0M |
May 04, 2023 | Prognos Health | Analytics | 23.3M |
Exits
41
Funding Timeline
129
1
0
Funding Rounds
129
Safeguard Scientifics has raised 129 rounds. Their latest funding was raised on May 04, 2023 from a Venture Round - Prognos Health round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Jan 11, 2021 | Venture Round - Moxe Health | - | 0 | - |
Jun 01, 2022 | Series B - Moxe Health | - | 30.0M | - |
Jul 27, 2022 | Venture Round - Syapse | - | 35.0M | - |
May 04, 2023 | Venture Round - Prognos Health | - | 23.3M | - |
Investors
1
Safeguard Scientifics is funded by 1 investor(s). HPS Investment Partners Kantor is the most recent investors.
Investor Name | Lead Investor | Funding Round | Money Raised |
---|---|---|---|
HPS Investment Partners | Yes | Post-IPO Debt - Safeguard Scientifics | 75.0M |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
News
Mar 26, 2024
Quartz - Safeguard Scientifics: Q4 Earnings Snapshot
News
Feb 12, 2024
GlobeNewswire - OTC Markets Group Welcomes Safeguard Scientifics, Inc. to OTCQX
News
Feb 12, 2024
Yahoo Finance - OTC Markets Group Welcomes Safeguard Scientifics, Inc. to OTCQX
News
Jan 05, 2024
GlobeNewswire News Room - Safeguard Scientifics Announces Effective Date of Stock Splits to Effectuate the Going Dark Transaction and New Chief Executive Officer and Chief Financial Officer
News
Nov 05, 2023
Yahoo Finance - Safeguard Scientifics, Inc. (NYSE:SFE) Q3 2023 Earnings Call Transcript
Funding Round
May 04, 2023
Prognos Health raised $23288367 on 2023-05-04 in Venture Round